Augmedix’s (AUGX) “Hold” Rating Reaffirmed at Lake Street Capital

Lake Street Capital reaffirmed their hold rating on shares of Augmedix (NASDAQ:AUGX) in a report published on Monday morning, Marketbeat.com reports.

A number of other equities analysts have also recently issued reports on AUGX. Maxim Group cut shares of Augmedix from a buy rating to a hold rating and set a $5.00 target price on the stock. in a report on Tuesday, May 14th. B. Riley lowered shares of Augmedix from a strong-buy rating to a hold rating and dropped their price target for the company from $3.00 to $2.35 in a research note on Friday, July 19th. Finally, Evercore ISI lowered shares of Augmedix from an outperform rating to an inline rating and dropped their price target for the company from $5.00 to $1.50 in a research note on Tuesday, May 14th. Four equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock presently has an average rating of Hold and an average target price of $3.09.

Augmedix Stock Performance

Shares of AUGX stock opened at $2.26 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 2.04 and a current ratio of 2.04. Augmedix has a one year low of $0.73 and a one year high of $6.25. The company’s 50-day simple moving average is $1.05 and its 200-day simple moving average is $2.92. The stock has a market capitalization of $110.67 million, a price-to-earnings ratio of -5.26 and a beta of -0.27.

Augmedix (NASDAQ:AUGX) last issued its earnings results on Monday, May 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.12). Augmedix had a negative net margin of 41.95% and a negative return on equity of 178.34%. The firm had revenue of $13.47 million for the quarter, compared to analysts’ expectations of $13.25 million. Equities analysts anticipate that Augmedix will post -0.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in AUGX. Russell Investments Group Ltd. increased its stake in shares of Augmedix by 292.0% during the fourth quarter. Russell Investments Group Ltd. now owns 891,077 shares of the company’s stock valued at $5,213,000 after acquiring an additional 663,778 shares during the period. Parkman Healthcare Partners LLC increased its stake in shares of Augmedix by 170.1% during the fourth quarter. Parkman Healthcare Partners LLC now owns 1,015,814 shares of the company’s stock valued at $5,943,000 after acquiring an additional 639,732 shares during the period. Ancora Advisors LLC increased its stake in shares of Augmedix by 102.7% during the first quarter. Ancora Advisors LLC now owns 444,660 shares of the company’s stock valued at $1,819,000 after acquiring an additional 225,330 shares during the period. Hood River Capital Management LLC grew its position in Augmedix by 79.0% in the first quarter. Hood River Capital Management LLC now owns 490,238 shares of the company’s stock worth $2,005,000 after buying an additional 216,339 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Augmedix by 16.0% in the first quarter. Vanguard Group Inc. now owns 1,302,424 shares of the company’s stock worth $5,327,000 after buying an additional 179,534 shares during the last quarter. Institutional investors and hedge funds own 87.11% of the company’s stock.

About Augmedix

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.